Christopher Kennerly Payne, MD
Urology · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Has dropped Medicare — you would pay privately
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Payne’s office at (650) 723-3391 to ask if they take your plan before you enroll.
California Medical Board record
Licence G74299 · Current
Licensed to practise in California · since 1992 · expires 2027-11-30 · Vanderbilt University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$8,676
Pharmacies billed $8,676 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 43% of their Part D prescriptions (13 of 30) in 2024. Too few prescriptions to compare fairly with other clinicians.
29 generic and fewer than 11 brand-name prescriptions · $8,676 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cyclosporine | 15 | $7,917 | $528 |
Year by year
| 2024 | 30 | None | 43% (13) | None | $8,676 |
| 2022 | 11 | None | 0% (0) | None | $6,179 |
| 2021 | 48 | None | None | 25% | $9,769 |
| 2020 | 46 | 13 | None | 28% | $13,354 |
| 2019 | 70 | 17 | None | 31% | $18,183 |
| 2018 | 72 | 18 | None | 38% | $20,073 |
| 2017 | 92 | 16 | None | 33% | $19,358 |
| 2016 | 108 | 24 | None | 37% | $21,871 |
| 2015 | 113 | 22 | None | 29% | $12,766 |
| 2014 | 239 | 71 | 5% (11) | None | $27,115 |
| 2013 | 470 | 130 | 9% (40) | 24% | $39,803 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 1 drug
| Gabapentin | 15 | $351 | $23 |
2019: 1 drug
| Myrbetriq | 16 | $12,629 | $789 |
2018: 2 drugs
| Myrbetriq | 20 | $12,119 | $606 |
| Cyclosporine | 11 | $4,472 | $407 |
2017: 2 drugs
| Myrbetriq | 27 | $13,030 | $483 |
| Amitriptyline | 15 | $343 | $23 |
2016: 2 drugs
| Myrbetriq | 23 | $9,673 | $421 |
| Cyclosporine | 18 | $5,737 | $319 |
2015: 2 drugs
| Myrbetriq | 22 | $5,776 | $263 |
| Amitriptyline | 14 | $221 | $16 |
2014: 9 drugs
| Elmiron | 16 | $10,461 | $654 |
| Vesicare | 18 | $3,878 | $215 |
| Premarin | 14 | $3,585 | $256 |
| Nitrofurantoin | 20 | $1,033 | $52 |
| Oxybutynin Chloride Er | 16 | $860 | $54 |
| Finasteride | 16 | $674 | $42 |
| Tamsulosin | 28 | $569 | $20 |
| Cephalexin | 28 | $138 | $5 |
| Amitriptyline | 11 | $80 | $7 |
2013: 15 drugs
| Elmiron | 13 | $9,170 | $705 |
| Vesicare | 26 | $5,493 | $211 |
| Premarin | 20 | $4,371 | $219 |
| Oxybutynin Chloride Er | 56 | $3,934 | $70 |
| Myrbetriq | 14 | $3,089 | $221 |
| Rimso-50 | 11 | $2,018 | $183 |
| Nitrofurantoin | 30 | $1,686 | $56 |
| Tamsulosin | 55 | $942 | $17 |
| Cephalexin | 37 | $350 | $9 |
| Hydrocodone-Acetaminophen | 32 | $285 | $9 |
| Terazosin | 14 | $178 | $13 |
| Sulfamethoxazole-Trimethoprim | 15 | $159 | $11 |
| Phenazopyridine | 12 | $139 | $12 |
| Ciprofloxacin | 21 | $119 | $6 |
| Amitriptyline | 20 | $107 | $5 |
Money from drug and device companies
$128 in 2020
| 2020 | 1 | 1 | None | $128 |
| 2019 | 1 | 1 | None | $110 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Allergan | Botox Cosmetic | $128 | 1 payment
|
See the published payment
| Allergan | Meals · 2020-09-18 | Botox Cosmetic | $128 |
See earlier years (2019)
2019: $110
| Medtronic USA | O-Arm-Spine | $110 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Takeda Pharmaceuticals U.S.A., Inc. · A Study of Tak-360 in Adults With Narcolepsy Without Cataplexy (Nt2) · 2025 | This clinician | $5,700 |
Professional record
- NPI
- 1649315292
- Licence
- CA G 74299California G74299: Current · expires 2027-11-30
More record details
- Sole proprietor
- No
- Taxonomy
- Urology (208800000X)
- Mailing address
- 11 Angela Dr, Los Altos, CA, 94022
- NPI first listed
- 2007-02-21
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.